Variant report
Variant | esv2476633 |
---|---|
Chromosome Location | chr13:76064673-76066024 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs367675000 | chr13:76064700-76064701 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs60330695 | chr13:76064708-76064709 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs397817657 | chr13:76064711-76064712 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs12866375 | chr13:76064712-76064713 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs201729762 | chr13:76064713-76064714 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs558110327 | chr13:76064725-76064726 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs79261020 | chr13:76064726-76064727 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs183623667 | chr13:76064731-76064732 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs112009706 | chr13:76064786-76064787 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs562247534 | chr13:76064825-76064826 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs186969450 | chr13:76064848-76064849 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs151204452 | chr13:76064853-76064854 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs576087053 | chr13:76064864-76064865 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs76548089 | chr13:76064867-76064868 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs563125970 | chr13:76064883-76064884 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs191822693 | chr13:76064887-76064888 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs543369868 | chr13:76064890-76064891 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs150342595 | chr13:76064920-76064921 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs527307728 | chr13:76064929-76064930 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs138807578 | chr13:76064987-76064988 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs559080948 | chr13:76065033-76065034 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs141607089 | chr13:76065162-76065163 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs372152886 | chr13:76065187-76065188 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs34946953 | chr13:76065190-76065191 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs1325463 | chr13:76065214-76065215 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs183559336 | chr13:76065229-76065230 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs188240838 | chr13:76065254-76065255 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs147046930 | chr13:76065267-76065268 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs575662836 | chr13:76065290-76065291 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs117123945 | chr13:76065339-76065340 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs536741719 | chr13:76065351-76065352 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs555773554 | chr13:76065395-76065396 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs77121643 | chr13:76065399-76065400 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs544951918 | chr13:76065455-76065456 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs138293648 | chr13:76065493-76065494 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs578228290 | chr13:76065498-76065499 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs574227118 | chr13:76065534-76065535 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs370370268 | chr13:76065548-76065549 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs34799761 | chr13:76065553-76065554 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs193034417 | chr13:76065585-76065586 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs559508636 | chr13:76065623-76065624 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs560595734 | chr13:76065668-76065669 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs144127081 | chr13:76065675-76065676 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs185727361 | chr13:76065678-76065679 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs571074191 | chr13:76065699-76065700 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs116589894 | chr13:76065726-76065727 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs551811584 | chr13:76065821-76065822 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs189808672 | chr13:76065859-76065860 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs534351310 | chr13:76065910-76065911 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs555779402 | chr13:76065937-76065938 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 21858162 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Prostate cancer | 21965145 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:76057000-76064800 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
2 | chr13:76060600-76069400 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
3 | chr13:76063400-76065000 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
4 | chr13:76063400-76065000 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
5 | chr13:76063600-76065000 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
6 | chr13:76063800-76068400 | Weak transcription | Spleen | Spleen |
7 | chr13:76064200-76067200 | Weak transcription | Liver | Liver |
8 | chr13:76064400-76064800 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
9 | chr13:76064400-76067400 | Weak transcription | Adipose Nuclei | Adipose |
10 | chr13:76064400-76069800 | Weak transcription | HSMM | muscle |
11 | chr13:76064400-76069800 | Weak transcription | HSMMtube | muscle |
12 | chr13:76064600-76065200 | Enhancers | GM12878-XiMat | blood |
13 | chr13:76064600-76067000 | Weak transcription | HepG2 | liver |
14 | chr13:76064600-76069000 | Weak transcription | Osteobl | bone |
15 | chr13:76064800-76070000 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |